文献速递糖尿病肥胖与代谢综合征

重新评估2型糖尿病缓解概念:呼吁以患者为中心的方法

Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-01-01

本文评估当前2型糖尿病缓解范式,指出基于2021年共识定义的缓解通常是暂时状态,多数人会出现体重反弹和疾病复发。持续缓解对部分人可能且与生活质量改善和并发症风险降低相关,但无确凿证据表明不用降糖药达到血糖正常和大幅减重比用药更有益。持续控制高血糖和减少肥胖可能比缓解本身更相关。

要点

  • 基于2021年共识定义,2型糖尿病缓解通常是暂时状态,多数人会出现体重反弹和疾病复发。
  • 持续缓解对部分人可能,与生活质量改善和微血管及大血管并发症风险降低相关。
  • 无确凿证据表明不用降糖药达到血糖正常和大幅减重比用药更有益。

核心结论

  • 持续控制高血糖和减少肥胖(无论通过手术、药物或生活方式干预)可能比缓解本身更相关。

研究设计与样本

  • 本文为综述,评估当前2型糖尿病缓解范式,强调定义间的不一致以及需要更符合临床现实和患者需求的方法。

主要发现

  • 基于2021年共识定义,2型糖尿病缓解通常通过减重实现,但似乎是暂时状态,多数人会出现体重反弹和疾病复发。
  • 持续2型糖尿病缓解对部分人可能,并与生活质量改善和微血管及大血管并发症风险降低相关。
  • 无确凿证据表明不用降糖药达到血糖正常和大幅减重比用药更有益。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and feasibility of remission warrant closer examination. Type 2 diabetes remission, typically attained through weight loss, appears to be a temporary state based on the 2021 consensus definition, with most individuals experiencing weight regain and relapse of the condition. Although sustained type 2 diabetes remission is possible for some individuals and is associated with improved quality of life and reduced risk for microvascular and macrovascular complications, no conclusive evidence exists to show that achieving normoglycaemia and substantial weight loss without glucose-lowering medications is more beneficial than with them. Sustained control of hyperglycaemia, along with reducing adiposity-whether through surgical, medical, or lifestyle interventions-could be more relevant than remission itself. Herein, we assess current remission paradigms, emphasising the discordance among definitions and the need for approaches that better align with clinical realities and patient needs.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Khunti K, Papamargaritis D, Aroda VR, et al. Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches. Lancet Diabetes Endocrinol. 2025. PMID: 40537183. doi:10.1016/S2213-8587(25)00134-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。